Category Archives: HIV prevention
Project Inform launches new educational videos on PrEP
Project Inform announced today the release of four new educational videos on the topic of PrEP, or Pre-Exposure Prophylaxis. PrEP is a new prevention tool that currently involves taking an HIV medication daily by an HIV-negative person to help prevent getting the virus. In July 2012,…Read More
Improving the nation’s response to identifying the nearly 240,000 Americans who don’t know they have HIV and get them into care is a key goal of the National HIV/AIDS Strategy. The FDA has taken another step towards that goal by approving the first rapid test that…Read More
USPSTF states most Americans should be tested for HIV
The US Preventive Services Task Force announced today that nearly all adolescents and adults in the United States should be screened for HIV infection. This final recommendation was based upon a review of current research on HIV screening as well as considering the information provided by…Read More
HIV vaccine study HVTN 505 stopped early
The National Institute of Allergy and Infectious Diseases (NIAID) announced last week that it will stop the experimental vaccine injections in its HVTN 505 Phase IIb clinical study. An independent monitoring board found during an early review of the data (April 22) that the HIV vaccine…Read More
CROI2013: Disappointing results of PrEP for women
A second clinical trial studying pre-exposure prophylaxis (PrEP) in women in Africa has found that the intervention was no more helpful than a placebo in preventing new HIV infections, but that once again this was highly likely due to the fact that very few women were…Read More
Less than daily PrEP dosing may be OK for some
Gay and bisexual men and transwomen who take their pre-exposure prophylaxis (PrEP) medications as few as four times per week may still have strong protection against becoming infected with HIV, according to a study published in the September 12 issue of Science Translational Medicine. The…Read More
Disappointing News about Selzentry as PrEP
A presentation at the International AIDS Conference in Washington, D.C. in August has concerned HIV prevention activists, because researchers found that the antiretroviral (ARV) drug Selzentry (maraviroc) didn’t work as well as they hoped at preventing infection from the monkey version of HIV in macaque monkeys….Read More